Skip to content

The Impact of the Therapeutic Virtual Reality Headset on Patient Anxiety in the Waiting Room Before Flexible Bronchoscopy in Vigil

The Impact of the Therapeutic Virtual Reality Headset on Patient Anxiety in the Waiting Room Before Flexible Bronchoscopy in Vigil

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06799806
Acronym
REVA
Enrollment
80
Registered
2025-01-29
Start date
2025-02-27
Completion date
2026-02-27
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial Fibroscopy

Keywords

virtual reality headset, anxiety

Brief summary

Bronchial fibroscopy is a frequently used procedure in the management of pneumology patients, and can be a source of anxiety, particularly while waiting for the examination. Investigator's professional experience has shown us that many patients are anxious in the waiting room before a flexible bronchoscopy in vigile. A great deal of research has been carried out into the use of virtual reality to reduce anxiety and pain during care but shortly before bronchoscopy. The innovative aspect is to target the patient's waiting time for the examination. Waiting is a highly anxiety-provoking time, and nurses play a vital role in supporting patients.

Interventions

20 minutes session with virtual reality device

Sponsors

Centre Hospitalier le Mans
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

single-center, prospective, interventional study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients with no age or gender restrictions, seen on an outpatient basis at Le Mans Hospital. * In whom bronchial fibroscopy is indicated. * Person affiliated with or benefiting from a social security . * Free, informed and written consent signed by the participant and the investigator (no later than the day of inclusion and before any examination required by the research). * Patient able and willing to answer questionnaires

Exclusion criteria

* Patient refusing to participate in research * Patient who has already undergone bronchoscopy in vigil * Patient premedicated for bronchial fibroscopy (anxiolytic, etc.) * Patients with a history of epilepsy or psychiatric pathology * Patient with vertigo * Patient uncooperative, demented or unable to tolerate headgear. * patient under guardianship or curatorship * Patients suffering from blindness or deafness * Patient with known significant intolerance to screens and/or virtual reality devices * Pregnant, nursing or parturient women * Unscheduled patients: emergencies, etc. * Hospitalized patients

Design outcomes

Primary

MeasureTime frameDescription
Anxiety assessmentImmediately after interventionAnxiety assessment is measured using a Numerical Rating Scale (NRS) from 0 to 10, supplemented by a self-assessment questionnaire before and after using the Therapeutic Virtual Reality Headset.

Secondary

MeasureTime frameDescription
Assessment of bronchoscopy realisation and sample collectionImmediately after interventionAssessment of whether bronchoscopy has been performed correctly in the vigile state, aas well as any sampling required, using a questionnaire completed by the nurse present during vigile flexible bronchoscopy.

Countries

France

Contacts

Primary ContactChristelle JADEAU
cjadeau@ch-lemans.fr+332 44 71 07 81

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026